Replies to post #83302 on Anavex Life Sciences Corp (AVXL)

[Jonjones325]

Yep. I believe Missling will have some updates at the CC. And they will be big. Why add in that little teaser about the CC in a PR about the CTAD?

[xodcode]

Yes, conference call too. Never before have we AVXL shareholders witnessed such a confluence of potentially positive events at a point in time:

1. Vastly undervalued share price vis a vis competition.

2. Growing validation of AVXL approach to AD.

3. At same time loss of momentum in competitor's science for AD.

4. Relatively small share count.

5. A molecule whose properties are readily transferable to myriad CHS diseases.

6. A board and scientific advisory group of the best of the best.

7. Relatively small portion of institutional ownership. (about to significantly and positively change).

Exciting and prosperous times most certainly await current shareholders.

[Dark Force]

This will most certainly be a significant price driver.

Time and time again, we see a ton of pumping leading up to these calls. These run-ups are rife with comments like, "Oh, I'm sure the good Dr. is going to have a few surprises in store for the shorts!" and similar twisted logic, all the while ignoring the fact that if bombshell information were to be released, trading would be halted.

It is almost comical to watch the huge dump take place while these highly anticipated events are in progress. (Take IM*P's FB presentation last week as a recent example.) And, to be clear, I am not saying this to mock delusional longs; rather, it is more of an indictment of my own gullibility. Unfortunately, I have losses to prove it.

So, if one is inclined to trade vs. simply buy-and-hold, this is something to keep in mind.

All of that being said, I have a renewed excitement for Anavex. It is especially encouraging to see your enthusiasm with regard to yesterday's data, kld. I have followed your posts since early '15 at the YMB, and appreciate your skeptically optimistic view of this company.